Nextgen rbis ORA firm development, modernization and enhancement (DME)

Ended Awarded Last action

Contract number
75F40124F19010
Awardee
Awarding agency
Obligated
$584,828

Award facts

Contract value 100% obligated
$584,828.03 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
North Bethesda, MD 20852, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00002 -$37,319
Other Administrative Action P00001 $0
Original award $622,147

About this award

The Food and Drug Administration issued a BPA call to Booz Allen Hamilton Inc. for NextGen RBIS ORA firm development, modernization, and enhancement, with a ceiling value of $584,828.03, awarded on September 17, 2024. The call is issued under the Multiple Award Schedule (MAS) BPA. Place of performance is North Bethesda, Maryland. The ultimate completion date is September 17, 2025. Work involves development, modernization, and enhancement services for the NextGen RBIS ORA system using labor hours pricing.

Quick answers

Who was awarded contract 75F40124F19010?

75F40124F19010 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on September 17, 2024.

How much is contract 75F40124F19010 worth?

The government has obligated $584,828 on 75F40124F19010.

Is contract 75F40124F19010 an order under another contract?

Yes. 75F40124F19010 is a BPA call under GS35F386DA-75F40122A00013, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40124F19010 competed?

The extent of competition for 75F40124F19010 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award